Jay A. Fishman Ltd’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-24,717
Closed -$3.6M 94
2017
Q3
$3.6M Buy
24,717
+50
+0.2% +$6.81K 0.73% 28
2017
Q2
$3.2M Buy
24,667
+1,000
+4% +$123K 0.68% 29
2017
Q1
$2.94M Hold
23,667
0.66% 30
2016
Q4
$2.74M Sell
23,667
-8,600
-27% -$958K 0.68% 30
2016
Q3
$3.37M Buy
32,267
+1,000
+3% +$108K 0.83% 29
2016
Q2
$3.08M Sell
31,267
-600
-2% -$62.1K 0.78% 29
2016
Q1
$3.19M Sell
31,867
-833
-3% -$85.8K 0.83% 29
2015
Q4
$3.92M Hold
32,700
0.95% 31
2015
Q3
$3.54M Hold
32,700
0.85% 32
2015
Q2
$3.78M Buy
32,700
+10,650
+48% +$1.22M 0.79% 30
2015
Q1
$2.54M Buy
+22,050
New +$2.63M 0.53% 35

Other funds holding CELG

Jay A. Fishman Ltd's CELG Position: Q4 2017 in Review

Jay A. Fishman Ltd sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 24,717 shares — an estimated $3.6M sold.

Jay A. Fishman Ltd first reported a position in CELG in Q1 2015 and held it in 11 quarters. The position peaked at $3.92M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Jay A. Fishman Ltd reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 24,717 Celgene Corp shares in Q4 2017, an estimated $3.6M.
  • Jay A. Fishman Ltd first reported a position in Celgene Corp in Q1 2015 and held it in 11 quarters.
  • Jay A. Fishman Ltd's Celgene Corp position peaked at $3.92M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Jay A. Fishman Ltd's 13F filing for Q4 2017, filed 5 Feb 2018.